Deborah M. Gurner

535 total citations
11 papers, 278 citations indexed

About

Deborah M. Gurner is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Deborah M. Gurner has authored 11 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Physiology. Recurrent topics in Deborah M. Gurner's work include Bone health and treatments (5 papers), Asthma and respiratory diseases (5 papers) and Bone Metabolism and Diseases (5 papers). Deborah M. Gurner is often cited by papers focused on Bone health and treatments (5 papers), Asthma and respiratory diseases (5 papers) and Bone Metabolism and Diseases (5 papers). Deborah M. Gurner collaborates with scholars based in United States, France and Chile. Deborah M. Gurner's co-authors include Barbara Knorr, Theodore F. Reiss, Albert Leung, Stuart A. Green, Carolyn DaSilva, Nadia Verbruggen, Steven S. Smugar, Carlos A. Camargo, Phyllis Della‐Latta and Sydney Lou Bonnick and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Deborah M. Gurner

11 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah M. Gurner United States 7 104 98 68 64 64 11 278
Tomoko Kagawa Japan 9 58 0.6× 147 1.5× 37 0.5× 28 0.4× 24 0.4× 44 250
Irzal Hadžibegović Croatia 8 10 0.1× 19 0.2× 44 0.6× 26 0.4× 51 0.8× 34 186
Deborah Blamble United States 4 17 0.2× 10 0.1× 44 0.6× 242 3.8× 56 0.9× 6 406
Yuta Kono Japan 11 144 1.4× 216 2.2× 89 1.3× 43 0.7× 20 0.3× 29 362
Nazim Nathani United Kingdom 7 46 0.4× 160 1.6× 76 1.1× 24 0.4× 8 0.1× 15 266
F Delrieu France 10 24 0.2× 19 0.2× 26 0.4× 21 0.3× 24 0.4× 34 260
R Vashisht United Kingdom 7 19 0.2× 54 0.6× 84 1.2× 28 0.4× 68 1.1× 15 289
Irina Strâmbu Romania 8 78 0.8× 104 1.1× 28 0.4× 26 0.4× 12 0.2× 43 204
S. Humbert France 7 26 0.3× 42 0.4× 41 0.6× 13 0.2× 45 0.7× 27 171
Paolo A. Bianchi Italy 12 20 0.2× 62 0.6× 141 2.1× 20 0.3× 9 0.1× 23 398

Countries citing papers authored by Deborah M. Gurner

Since Specialization
Citations

This map shows the geographic impact of Deborah M. Gurner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah M. Gurner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah M. Gurner more than expected).

Fields of papers citing papers by Deborah M. Gurner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah M. Gurner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah M. Gurner. The network helps show where Deborah M. Gurner may publish in the future.

Co-authorship network of co-authors of Deborah M. Gurner

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah M. Gurner. A scholar is included among the top collaborators of Deborah M. Gurner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah M. Gurner. Deborah M. Gurner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Saag, Kenneth G., T. J. de Villiers, Peter Alexandersen, et al.. (2020). Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. Journal of the American Academy of Dermatology. 84(4). 1113–1119. 2 indexed citations
2.
Woo, Tiffany, et al.. (2018). Incidence of hypersensitivity and anaphylaxis with sugammadex. Journal of Clinical Anesthesia. 47. 67–73. 21 indexed citations
3.
Rizzoli, R., C.L. Benhamou, Johan Halse, et al.. (2016). Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study. Osteoporosis International. 27(6). 2099–2107. 31 indexed citations
4.
Bonnick, Sydney Lou, Alberto Odio, Santiago Palacios, et al.. (2013). Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4727–4735. 47 indexed citations
5.
6.
Palacios, Santiago, Sydney Lou Bonnick, R. Chapurlat, et al.. (2013). OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate– a Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases. 72. A136–A136. 1 indexed citations
7.
Valovirta, Erkka, Colin F. Robertson, Nadia Verbruggen, et al.. (2011). Intermittent or daily montelukast versus placebo for episodic asthma in children. Annals of Allergy Asthma & Immunology. 106(6). 518–526. 40 indexed citations
8.
Morris, Claudia R., Allan B. Becker, Rachid Massaad, et al.. (2010). A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Annals of Allergy Asthma & Immunology. 104(2). 161–171. 20 indexed citations
9.
Camargo, Carlos A., Deborah M. Gurner, Howard Smithline, et al.. (2010). A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. Journal of Allergy and Clinical Immunology. 125(2). 374–380. 59 indexed citations
10.
Nelsen, Linda, et al.. (2008). Measuring Severity of Acute Asthma in Pediatric Patients. Journal of Allergy and Clinical Immunology. 121(2). S80–S80. 1 indexed citations
11.
Della‐Latta, Phyllis, Vivek Kapur, Luigi Palumbo, et al.. (1996). Independent Origin of Mono-Rifampin-Resistant Mycobacterium Tuberculosis in Patients With AIDS. American Journal of Respiratory and Critical Care Medicine. 153(2). 837–840. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Kagawa Breakdown of academic impact, for papers by Irzal Hadžibegović Breakdown of academic impact, for papers by Deborah Blamble Breakdown of academic impact, for papers by Yuta Kono Breakdown of academic impact, for papers by Nazim Nathani Breakdown of academic impact, for papers by F Delrieu Breakdown of academic impact, for papers by R Vashisht Breakdown of academic impact, for papers by Irina Strâmbu Breakdown of academic impact, for papers by S. Humbert Breakdown of academic impact, for papers by Paolo A. Bianchi
Rankless by CCL
2026